Edify Acquisition Corp. EAC
Set alert
10.65 0.00 0.00%
As of Mar 11, 2:40 PM ET
10.62 Day range 10.65
52-week range unavailable
- Open
- 10.64
- Prev close
- 10.65
- Mkt cap
- 84.03M
- Vol
- 46.70K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.62
- High
- 10.65
- Forward P/E
- 0.00
- Beta
- 0.04
- Short ratio
- 0.07
- Inst. own
- 10.32%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 11.17
- 200-d avg
- 10.92
- 1y target
- 0.00
Key statistics
- Market cap
- 84.03M
- Enterprise value
- 87.02M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.03
- Beta
- 0.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -746.82K
- Total cash
- 57.73K
- Total debt
- 3.04M
- Return on equity
- 0.00%
- Shares outstanding
- 7.89M
- Short % of float
- 0.05%
- 50-day average
- 11.17
- 200-day average
- 10.92
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
EAC Revenue — quarterly 0
EAC Net income — quarterly -169.69K
EAC EPS — quarterly -0.02
About Edify Acquisition Corp.
Edify Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Edify Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- edifyacq.com
News
- Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
- Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers
- Newmont's Red Chris Block Cave Project Receives Major Regulatory Approvals
- KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema
- Green Technologies in Action: Earth Alive and Eldorado Gold Quebec Collaborate for Responsible Mining Operations
- Cross-border tour operators key to tourism sector recovery
- Deploy Kiswahili language teachers – Kadaga
- Edify Acquisition Corp. to Liquidate
- Unique Logistics International Reports Fiscal First Quarter Financial Results
- Museveni: Kiswahili is major ingredient in accelerating EAC integration
Your note
Sign in to keep a note on EAC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bracebridge Capital, LLC | 29.63% | 500,000 | 5.29M | Jun 29, 2023 |
| Clear Street LLC | 10.37% | 175,036 | 1.85M | Jun 29, 2023 |
| Castle Creek Arbitrage, Llc | 8.89% | 150,000 | 1.59M | Jun 29, 2023 |
| Periscope Capital Inc. | 8.89% | 150,000 | 1.59M | Jun 29, 2023 |
| Polar Asset Management Partners Inc. | 8.89% | 150,000 | 1.59M | Jun 29, 2023 |
| Fir Tree Capital Management Lp | 8.77% | 148,001 | 1.57M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 1.27% | 21,442 | 224.28K | May 30, 2023 |